Cargando…
Rare disease education in Europe and beyond: time to act
People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of r...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761619/ https://www.ncbi.nlm.nih.gov/pubmed/36536417 http://dx.doi.org/10.1186/s13023-022-02527-y |
_version_ | 1784852715843616768 |
---|---|
author | Tumiene, Birute Peters, Harm Melegh, Bela Peterlin, Borut Utkus, Algirdas Fatkulina, Natalja Pfliegler, György Graessner, Holm Hermanns, Sanja Scarpa, Maurizio Blay, Jean-Yves Ashton, Sharon McKay, Lucy Baynam, Gareth |
author_facet | Tumiene, Birute Peters, Harm Melegh, Bela Peterlin, Borut Utkus, Algirdas Fatkulina, Natalja Pfliegler, György Graessner, Holm Hermanns, Sanja Scarpa, Maurizio Blay, Jean-Yves Ashton, Sharon McKay, Lucy Baynam, Gareth |
author_sort | Tumiene, Birute |
collection | PubMed |
description | People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of rare disease knowledge and awareness among the current and future HWF is insufficient. In recent years, many educational resources on rare diseases have been developed, however, awareness of these resources is still limited and rare disease education is still not sufficiently taken into account by some crucial stakeholders as academia and professional organizations. Therefore, there is a need to fundamentally rethink rare disease education and HWF development across the whole spectrum from students to generalists, specialists and experts, to engage and empower PLWRD, their families and advocates, and to work towards a common coherent and complementary strategy on rare disease education and training in Europe and beyond. Special consideration should be also given to the role of nurse coordinators in care coordination, interprofessional training for integrated multidisciplinary care, patient and family-centered education, opportunities given by digital learning and fostering of social accountability to enforce the focus on socially-vulnerable groups such as PLWRD. The strategy has to be developed and implemented by multiple rare disease education and training providers: universities, medical and nursing schools and their associations, professional organizations, European Reference Networks, patient organizations, other organizations and institutions dedicated to rare diseases and rare cancers, authorities and policy bodies. |
format | Online Article Text |
id | pubmed-9761619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97616192022-12-19 Rare disease education in Europe and beyond: time to act Tumiene, Birute Peters, Harm Melegh, Bela Peterlin, Borut Utkus, Algirdas Fatkulina, Natalja Pfliegler, György Graessner, Holm Hermanns, Sanja Scarpa, Maurizio Blay, Jean-Yves Ashton, Sharon McKay, Lucy Baynam, Gareth Orphanet J Rare Dis Position Statement People living with rare diseases (PLWRD) still face huge unmet needs, in part due to the fact that care systems are not sufficiently aligned with their needs and healthcare workforce (HWF) along their care pathways lacks competencies to efficiently tackle rare disease-specific challenges. Level of rare disease knowledge and awareness among the current and future HWF is insufficient. In recent years, many educational resources on rare diseases have been developed, however, awareness of these resources is still limited and rare disease education is still not sufficiently taken into account by some crucial stakeholders as academia and professional organizations. Therefore, there is a need to fundamentally rethink rare disease education and HWF development across the whole spectrum from students to generalists, specialists and experts, to engage and empower PLWRD, their families and advocates, and to work towards a common coherent and complementary strategy on rare disease education and training in Europe and beyond. Special consideration should be also given to the role of nurse coordinators in care coordination, interprofessional training for integrated multidisciplinary care, patient and family-centered education, opportunities given by digital learning and fostering of social accountability to enforce the focus on socially-vulnerable groups such as PLWRD. The strategy has to be developed and implemented by multiple rare disease education and training providers: universities, medical and nursing schools and their associations, professional organizations, European Reference Networks, patient organizations, other organizations and institutions dedicated to rare diseases and rare cancers, authorities and policy bodies. BioMed Central 2022-12-19 /pmc/articles/PMC9761619/ /pubmed/36536417 http://dx.doi.org/10.1186/s13023-022-02527-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Position Statement Tumiene, Birute Peters, Harm Melegh, Bela Peterlin, Borut Utkus, Algirdas Fatkulina, Natalja Pfliegler, György Graessner, Holm Hermanns, Sanja Scarpa, Maurizio Blay, Jean-Yves Ashton, Sharon McKay, Lucy Baynam, Gareth Rare disease education in Europe and beyond: time to act |
title | Rare disease education in Europe and beyond: time to act |
title_full | Rare disease education in Europe and beyond: time to act |
title_fullStr | Rare disease education in Europe and beyond: time to act |
title_full_unstemmed | Rare disease education in Europe and beyond: time to act |
title_short | Rare disease education in Europe and beyond: time to act |
title_sort | rare disease education in europe and beyond: time to act |
topic | Position Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761619/ https://www.ncbi.nlm.nih.gov/pubmed/36536417 http://dx.doi.org/10.1186/s13023-022-02527-y |
work_keys_str_mv | AT tumienebirute rarediseaseeducationineuropeandbeyondtimetoact AT petersharm rarediseaseeducationineuropeandbeyondtimetoact AT meleghbela rarediseaseeducationineuropeandbeyondtimetoact AT peterlinborut rarediseaseeducationineuropeandbeyondtimetoact AT utkusalgirdas rarediseaseeducationineuropeandbeyondtimetoact AT fatkulinanatalja rarediseaseeducationineuropeandbeyondtimetoact AT pflieglergyorgy rarediseaseeducationineuropeandbeyondtimetoact AT graessnerholm rarediseaseeducationineuropeandbeyondtimetoact AT hermannssanja rarediseaseeducationineuropeandbeyondtimetoact AT scarpamaurizio rarediseaseeducationineuropeandbeyondtimetoact AT blayjeanyves rarediseaseeducationineuropeandbeyondtimetoact AT ashtonsharon rarediseaseeducationineuropeandbeyondtimetoact AT mckaylucy rarediseaseeducationineuropeandbeyondtimetoact AT baynamgareth rarediseaseeducationineuropeandbeyondtimetoact |